Katalog der Deutschen Nationalbibliothek
Ergebnis der Suche nach: "test"
|
|
|
| Link zu diesem Datensatz | https://d-nb.info/gnd/134046560 |
| Person | Schneider, Christian |
| Akademischer Grad | Dr. |
| Weitere Angaben |
Tätig FiveLakes Venture Partners, München Dr. Schneider has extensive work and investment experience in the areas of diagnostics and medical R&D. Based on a doctorate in veterinary medicine and a PhD in immunology, he has a medical and life science background that spans diverse disciplines such as food sciences, oncology, immunology, surgery, infectious diseases, and molecular biology. He brings 14 years of operational, scientific, and product development experience in the diagnostic and biopharmaceutical industry from positions of increasing responsibility at Boehringer Mannheim/Roche, Centocor (a Johnson & Johnson company), and PolyTechnos. During his time at Boehringer Mannheim/Roche (Germany, 1992-1995), he was responsible for the development of the first fully automated test for the detection of free PSA, a new prostate cancer marker, which is marketed by Roche worldwide. At Centocor (Philadelphia, USA, 1995-2000), he led the development of a panel of tumor marker tests for ovarian, colon, and breast cancer that involved transatlantic collaboration and technology transfer between Centocor and Boehringer Mannheim/Roche. Moreover, as a business developer and external research manager, he gained experience in the licensing of products, negotiation of licensing agreements, budgets, and project management. In 2001, after 6 years with Centocor, he joined PolyTechnos in Munich, Germany, initially as an Investment Manager, then as a Partner (in 2002) and Managing Partner (in 2006). As a lead partner, he played a key role in shaping the strategy of PolyTechnos |
| Typ | Person (piz) |

